Geode Capital Management
INBS icon

Geode Capital Management’s Intelligent Bio Solutions INBS Stock Holding History

Geode Capital Management’s Portfolio INBS Stock Details INBS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$47.8K Sell
20,840
-7,769
-27% -$20.4K ﹤0.01% 4257
2026
Q1 		$95.7K Buy
+28,609
New +$198K ﹤0.01% 4148
2025
Q4 		– Sell
-5,887
Closed -$60K – 4513
2025
Q3 		$60K Buy
5,887
+742
+14% +$12K ﹤0.01% 4251
2025
Q2 		$88.5K Buy
5,145
+244
+5% +$3.51K ﹤0.01% 4095
2025
Q1 		$70.6K Buy
4,901
+2,241
+84% +$41.8K ﹤0.01% 4118
2024
Q4 		$37.2K Buy
2,660
+389
+17% +$5.93K ﹤0.01% 4288
2024
Q3 		$39.3K Buy
2,271
+365
+19% +$5.69K ﹤0.01% 4308
2024
Q2 		$36.6K Buy
1,906
+474
+33% +$12.1K ﹤0.01% 4341
2024
Q1 		$60.4K Buy
1,432
+1,329
+1,290% +$55K ﹤0.01% 4285
2023
Q4 		$4.18K Hold
103
– – ﹤0.01% 4645
2023
Q3 		$13K Buy
+103
New +$23.4K ﹤0.01% 4693
2023
Q1 		– Sell
-48
Closed -$23K – 4815
2022
Q4 		$23K Hold
48
– – ﹤0.01% 4745
2022
Q3 		$48K Hold
48
– – ﹤0.01% 4774
2022
Q2 		$76K Buy
48
+1
+2% +$1.69K ﹤0.01% 4678
2022
Q1 		$88K Buy
+47
New +$108K ﹤0.01% 4696
2021
Q4 		– Sell
-45
Closed -$273K – 4987
2021
Q3 		$273K Buy
45
+40
+800% +$307K ﹤0.01% 4309
2021
Q2 		$43K Buy
+5
New +$47.8K ﹤0.01% 4674

Other funds holding INBS

AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

Geode Capital Management's INBS Position: Q2 2026 in Review

Geode Capital Management reduced its Intelligent Bio Solutions (INBS) stake by 27% in Q2 2026, selling an estimated $20.4K and leaving 20,840 shares worth $47.8K. The position accounts for ﹤0.01% of the portfolio, ranked #4257.

Geode Capital Management first reported a position in INBS in Q2 2021 and has held it in 17 quarters since. The position peaked at $273K in Q3 2021. 8 funds tracked by Wall St. Rank hold INBS as of Q2 2026.

  • Geode Capital Management held 20,840 shares of Intelligent Bio Solutions worth $47.8K as of Q2 2026.
  • Geode Capital Management sold 7,769 Intelligent Bio Solutions shares in Q2 2026, an estimated $20.4K.
  • Intelligent Bio Solutions made up ﹤0.01% of Geode Capital Management's portfolio in Q2 2026, its #4257 holding.
  • Geode Capital Management first reported a position in Intelligent Bio Solutions in Q2 2021 and has held it in 17 quarters since.
  • Geode Capital Management's Intelligent Bio Solutions position peaked at $273K in Q3 2021.
  • 8 funds tracked by Wall St. Rank held Intelligent Bio Solutions as of Q2 2026.

Based on Geode Capital Management's 13F filing for Q2 2026, filed 12 Aug 2026.